iTeos Therapeutics, Inc. (ITOS)

NASDAQ: ITOS · IEX Real-Time Price · USD

14.44

-0.57 (-3.80%)

At close: Jul 2, 2024, 4:00 PM

14.72

+0.28 (1.94%)

After-hours: Jul 2, 2024, 4:06 PM EDT

iTeos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	522	392	695	1,642	1,185
Market Cap Growth	0.56%	-43.60%	-57.70%	38.57%	-
Enterprise Value	78	-134	86	799	849
PE Ratio	-	-3.48	7.19	7.66	-27.31
PS Ratio	-	31.11	2.60	4.76	-
PB Ratio	0.96	0.68	1.05	2.97	3.67
P/FCF Ratio	-4.31	-3.67	-6.20	3.21	-46.42
P/OCF Ratio	-4.46	-3.78	-6.25	3.20	-47.08
EV/Sales Ratio	-	-10.66	0.32	2.32	-
EV/EBITDA Ratio	-0.35	1.24	0.58	3.11	-22.60
EV/EBIT Ratio	-0.35	1.23	0.58	3.11	-22.28
EV/FCF Ratio	-0.40	1.26	-0.77	1.56	-33.24
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-0.04	-0.06	0.03	0.02	-
Debt / FCF Ratio	-0.05	-0.06	-0.04	0.01	-
Quick Ratio	12.64	13.30	14.63	2.80	22.44
Current Ratio	13.51	13.76	14.96	2.88	22.64
Asset Turnover	0	0.02	0.34	0.56	0
Return on Equity (ROE)	-23.10%	-18.40%	15.10%	56.20%	-30.30%
Return on Assets (ROA)	-20.20%	-16.20%	12.10%	34.90%	-17.50%
Return on Capital (ROIC)	-31.68%	-25.99%	12.29%	36.70%	-14.00%
Earnings Yield	-25.94%	-28.75%	13.91%	13.06%	-3.66%
FCF Yield	-21.74%	-27.24%	-16.14%	31.17%	-2.15%
Buyback Yield / Dilution	-0.36%	5.30%	0.02%	-150.49%	-7336.29%
Total Shareholder Return	-0.36%	5.30%	0.02%	-150.49%	-7336.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).